UFM1 inhibitors belong to a class of chemical compounds with an ability to modulate specific cellular processes. UFM1, or Ubiquitin-Fold Modifier 1, is a protein that plays a crucial role in the post-translational modification of other proteins, a process essential for regulating various cellular functions. UFM1 is involved in the UFM1 conjugation system, where it is covalently attached to target proteins in a manner similar to ubiquitin. This modification can influence protein stability, localization, and interactions, thereby affecting cellular processes such as protein turnover and quality control. UFM1 inhibitors are designed to interact with the active site or binding domain of the UFM1 protein, effectively inhibiting its function and influencing cellular processes dependent on UFM1-mediated protein modification.
Structurally, UFM1 inhibitors are carefully engineered to selectively target the active site of UFM1, ensuring high specificity for this particular modifier protein. By inhibiting UFM1, these compounds may disrupt the normal process of UFM1 conjugation to target proteins, affecting the stability and function of those modified proteins. The study of UFM1 inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions, particularly in the context of post-translational modifications and protein quality control. This knowledge contributes to our understanding of basic cell biology and may have implications in various research areas, including protein homeostasis, cellular stress responses, and the molecular basis of diseases associated with protein misfolding or dysfunction. However, further research is required to fully explore the extent of their applications and their impact on cellular physiology in the context of UFM1-mediated protein modification.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, potentially leading to decreased overall protein levels, including UFM1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR signaling, which could lead to a general reduction in protein synthesis and potentially impact UFM1 levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the proteasome, potentially causing changes in protein turnover that might affect UFM1 levels. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, stressing the ER and potentially reducing UFM1 expression due to ER stress response. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin induces ER stress by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), which could affect UFM1 levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that can affect the degradation of proteins, potentially altering UFM1 expression. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Epoxomicin is a selective proteasome inhibitor, which could lead to changes in cellular protein levels, including UFM1. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
2-Deoxy-D-glucose inhibits glycolysis, which can lead to energy stress in cells and possibly impact UFM1 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid can modulate gene expression, which might have an indirect effect on UFM1 expression levels. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
Spautin-1 is known to inhibit the deubiquitinating activity of USP10 and USP13, potentially influencing UFM1 levels indirectly. | ||||||